🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present study will explore the immunogenicity of AVAXIM™ 80U-Pediatric ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00313950
Malaria and iron deficiency cause a significant burden of disease in Africa...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-05
Trial ID
NCT06816524
Treatments Being Tested
Measles is a preventable infectious viral disease. Since 1985, India has be...
Status
Unknown
Location
Postgraduate Institute of Medical Education and Research
Start Date
2017-03-14
Trial ID
NCT03170765
Treatments Being Tested
Few data exist on long-term persistence of measles antibodies after vaccina...
Status
Completed
Location
Bandim Health Project
Start Date
2002-03
Trial ID
NCT00168571
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
This is a phase 1b/II, open label, multicenter study of IBI310 (Anti-CTLA4 ...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2021-07-23
Trial ID
NCT04945421
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
To evaluate the consistency of drug efficacy between the clinical systemic ...
Status
Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2025-03-26
Trial ID
NCT06686979
Treatments Being Tested
Regorafenib is an oral medication that can interfere with cancer cell growt...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-03
Trial ID
NCT02098538
Treatments Being Tested